Protein therapies have been developed to bind numerous disease-associated targets but can cause off-site toxicities when healthy tissues also express their target. Therefore, emergent strategies have designed masked, conditionally activated protein therapies. This review focuses on the design and effectiveness of protein-based masks for cytokines, antibodies, and their derivatives.